ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year no longer needed to inject insulin at all.
Researchers say the study marks a promising approach that could one day relieve some people with type 1 diabetes of the need for daily insulin injections.
“These cells clearly work,” said Jay Skyler, an endocrinologist at the University of Miami Miller School of Medicine who was not involved in the study.
Click this link for the original source of this article.
Author: Elizabeth Cooney
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.